Sensus Healthcare director William McCall passes
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
Sensus Healthcare Announces the Passing of Director Bill McCall
October 31, 2025 8:00 AM EDTBOCA RATON, Fla.--(BUSINESS WIRE)-- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, announces the passing of longtime friend of the Company and current Director William Bill McCall.
Bills involvement with Sensus dates to 2009, when he played a key role in transforming the company from concept to reality. He led the Companys initial capital raise in 2010 while serving as CEO of Anderson Strudwick, a boutique investment banking firm. He joined the Sensus Healthcare Board of... More
